GW Pharma Q2 Revenue Increases Marginally From Q1 to $121.6 Million

New Cannabis Ventures
By NCV NewswireAug 6, 2020, 4:27 pm276 pts
GW Pharmaceuticals plc Reports Second Quarter 2020 Financial Results and Operational Progress Total revenue increased 68 percent to $121.3 million Epidiolex approved in the U.S. for seizures associated with TSC, launch expected this month Conference call today at 4:30 p.m. EDT LONDON and CARLSBAD, Calif., Aug.…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Florida’s Cannabis Market Is Crumbling 79

Cannabis Reform Group MPP Names Adam J. Smith Executive Director 78

Flowhub launches new online cannabis ordering platform 78

Pure Sunfarms Publishes Unique Cannabis Potency Research in Scientific Reports 75

US Congressman Denounces ICE’s Claim He ‘Doxed’ Federal Employee at Cannabis Raids 75

First New Jersey Marijuana Consumption Lounges Get Official Approval In ‘Major Milestone’ 75

Battle Between Intoxicating Hemp And Marijuana Industries Picks Up In St. Louis 72

Senate advances bipartisan proposal to ban most hemp-derived THC products 72

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.